SCHEMBL13808367

SCHEMBL13808367

Cc1ccc(OC(F)(F)c2ccc(Cc3ccc(C(F)(F)Oc4ccc(C)cc4)cc3)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.42
BCHE P06276 2/20 0.42
SLC6A4 P31645 2/20 0.39
KCNH2 Q12809 2/20 0.39
HTR2A P28223 1/20 0.39
KIF11 P52732 1/20 0.36
LTA4H P09960 1/20 0.36
ELANE P08246 1/20 0.36
MAPT P10636 1/20 0.36
OPRK1 P41145 1/20 0.35
EPHX2 P34913 1/20 0.35
NR1H4 Q96RI1 1/20 0.35
SRD5A2 P31213 1/20 0.35
CETP P11597 1/20 0.34
TSHR P16473 1/20 0.34
AGXT P21549 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA5A P35218 1/20 0.34
CA9 Q16790 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13808351 0.89 MAPT (0.42) ACHEBCHESLC6A4KCNH2HTR2A
SCHEMBL13104749 0.89 ACHE (0.42) ACHEBCHESLC6A4KCNH2HTR2A
SCHEMBL12829128 0.89 ACHE (0.42) ACHEBCHESLC6A4KCNH2HTR2A
SCHEMBL7730645 0.89 ACHE (0.42) ACHEBCHESLC6A4KCNH2HTR2A
SCHEMBL7733360 0.88 BCHE (0.44) ACHEBCHESLC6A4KCNH2HTR2A
SCHEMBL7733321 0.85 BCHE (0.40) ACHEBCHESLC6A4KCNH2HTR2A
SCHEMBL10018707 0.83 ACHE (0.38) ACHEBCHESLC6A4KCNH2HTR2A
SCHEMBL12152581 0.83 ACHE (0.38) ACHEBCHESLC6A4KCNH2HTR2A
SCHEMBL7729109 0.83 ACHE (0.45) ACHEBCHEKCNH2KIF11MAPT
SCHEMBL13808376 0.82 KCNH2 (0.41) ACHEBCHEKCNH2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544400-B2 Bimesogenic compounds and flexoelectric devices MERCK PATENT GMBH (DE) 2009-06-09 US disclosed
US-20080142758-A1 Bimesogenic Compounds And Flexoelectric Devices MERCK PATENT GMBH (DE) 2008-06-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080142758-A1 Bimesogenic Compounds And Flexoelectric Devices MLX, FOXM1, SFXN1 ACHE 4124/4885BCHE 4661/4885SLC6A4 3648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.